COEPTIS THERAPEUTICS HLDGS I's ticker is and the CUSIP is 19207A116. A total of 19 filers reported holding COEPTIS THERAPEUTICS HLDGS I in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,080 | – | 10,806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ionic Capital Management LLC | 518,728 | $38,645 | 0.01% |
| Kepos Capital LP | 250,000 | $19 | 0.00% |
| METEORA CAPITAL, LLC | 148,443 | $11,059 | 0.00% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 150,000 | $10,755 | 0.00% |
| SkyView Investment Advisors, LLC | 55,122 | $4 | 0.00% |
| CSS LLC/IL | 73,748 | $10,575 | 0.00% |
| WELLS FARGO & COMPANY/MN | 152,354 | $10,924 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Radcliffe Capital Management, L.P. | 70,506 | $5,253 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 22,934 | $1,644 | 0.00% |